Latest News by Industry
Today, Centene announced Leslie V. Norwalk, Esq. has been appointed to the Centene Board of Directors.
Ms. Norwalk previously served on the Board of Magellan Health, which Centene recently acquired. She is an experienced director and throughout her accomplished career has served on boards across a wide spectrum of healthcare corporations and biotechnology companies, including NuVasive, Endologix, Providence Services Corporation, Neurocrine Biosciences and Arvinas.
"Leslie’s extensive leadership and experience in the Government Healthcare and Biotech industries brings invaluable perspective to our Board as we continue to expand our efforts to bring on trusted advisors to help us deliver on the goals in our Value Creation Plan," said Michael Neidorff, Centene's Chairman and Chief Executive Officer. "She brings a fresh perspective that will help us maintain our mission while expanding our service of providing accessible, high-quality healthcare to our most vulnerable populations."
Ms. Norwalk currently serves as Strategic Counsel to Epstein Becker Green, P.C., a law firm specialized in healthcare and life science industries. She also serves as an advisor to three private equity firms in healthcare policy and regulatory matters.
Ms. Norwalk began her career in the public sector, serving as the Administrator for the Centers for Medicare & Medicaid Services (CMS) under the Bush Administration. She later went on to serve as the Deputy, and later, Acting Administrator for the agency, as well as their Counselor and Policy Advisor.
"It is a pleasure to join Centene’s Board of Directors during such an impactful time of change and growth for the company and healthcare industry as a whole. I’m honored to continue expanding the opportunities to provide top-quality healthcare in the communities that need it most, and support Centene in its goals of transforming the health of the communities it serves," said Norwalk. "This is the core service of managed care, and I look forward to bringing a fresh perspective and new value to this vital mission of creating better health outcomes for our community."